Holdings
BIOS Capital Management, LP
As of Sep 30, 2026, BIOS Capital Management, LP reported 6 positions worth US$34.2M. Largest: Opus Genetics, Inc., Actuate Therapeutics, Inc. and Cognition Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Opus Genetics, Inc. | 3.68M | US$17.8M | no change | Sep 30, 2026 |
| Actuate Therapeutics, Inc. | 10M | US$7.84M | no change | Sep 30, 2026 |
| Cognition Therapeutics, Inc. | 6M | US$5.76M | no change | Sep 30, 2026 |
| Rein Therapeutics, Inc. | 2.98M | US$2.4M | no change | Sep 30, 2026 |
| Lantern Pharma Inc. | 236K | US$238K | −13,502 | Sep 30, 2026 |
| IN8bio, Inc. | 80,957 | US$108K | no change | Sep 30, 2026 |